Orthofix International | OFIX - Equity Capital And Reserves


Orthofix International reported $429.18M in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Accuray USD 53.42M 8.45M Dec/2025
AngioDynamics USD 176.33M 2.52M Sep/2025
Artivion USD 445.58M 4.88M Jun/2026
AtriCure USD 516.43M 24.74M Jun/2026
Dexcom USD 2.62B 335.5M Jun/2026
EDAP TMS EUR 10.1M 13.22M Mar/2026
Globus Medical USD 4.77B 36.29M Jun/2026
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.42B 119.6M Jun/2026
Integra LifeSciences USD 1.04B 971K Jun/2026
J&J USD 84.97B 3.78B Jun/2026
Medtronic USD 48.99B 128M Dec/2025
Mesa Laboratories USD 186.69M 8.22M Dec/2025
Orthofix International USD 429.18M 6.01M Jun/2026
Plus Therapeutics USD 5.46M 6.5M Jun/2026
Smith & Nephew USD 5.18B 356M Jun/2026
STAAR Surgical USD 365.4M 13.03M Jun/2026
Stryker USD 22.98B 559M Mar/2026
Tandem Diabetes Care USD 130.39M 2.02M Jun/2026
Teleflex USD 2.9B 179.9M Jun/2026
Veracyte USD 1.39B 44M Jun/2026
Zimmer Biomet Holdings USD 12.63B 49.1M Jun/2026